This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 28 |
NetGPI | no | yes: 0, no: 28 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 24 |
GO:0110165 | cellular anatomical entity | 1 | 24 |
Related structures:
AlphaFold database: E9AK86
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 5 |
GO:0006644 | phospholipid metabolic process | 4 | 5 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 5 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 5 |
GO:0006793 | phosphorus metabolic process | 3 | 5 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 4 | 5 |
GO:0008654 | phospholipid biosynthetic process | 5 | 5 |
GO:0009058 | biosynthetic process | 2 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019637 | organophosphate metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044249 | cellular biosynthetic process | 3 | 5 |
GO:0044255 | cellular lipid metabolic process | 3 | 5 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 5 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 5 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 5 |
GO:0046486 | glycerolipid metabolic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090407 | organophosphate biosynthetic process | 4 | 5 |
GO:1901576 | organic substance biosynthetic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 29 |
GO:0016740 | transferase activity | 2 | 29 |
GO:0016746 | acyltransferase activity | 3 | 29 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 8 |
GO:0008374 | O-acyltransferase activity | 5 | 8 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 8 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 8 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 8 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 127 | 133 | PF00089 | 0.532 |
CLV_NRD_NRD_1 | 275 | 277 | PF00675 | 0.683 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.301 |
CLV_PCSK_FUR_1 | 273 | 277 | PF00082 | 0.615 |
CLV_PCSK_KEX2_1 | 273 | 275 | PF00082 | 0.702 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.277 |
CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.744 |
CLV_PCSK_SKI1_1 | 3 | 7 | PF00082 | 0.372 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.230 |
DOC_CYCLIN_yCln2_LP_2 | 22 | 28 | PF00134 | 0.415 |
DOC_MAPK_gen_1 | 200 | 209 | PF00069 | 0.317 |
DOC_MAPK_gen_1 | 33 | 41 | PF00069 | 0.517 |
DOC_MAPK_MEF2A_6 | 34 | 43 | PF00069 | 0.531 |
DOC_PP1_RVXF_1 | 47 | 54 | PF00149 | 0.330 |
DOC_PP2B_LxvP_1 | 12 | 15 | PF13499 | 0.421 |
DOC_PP2B_LxvP_1 | 29 | 32 | PF13499 | 0.607 |
DOC_PP2B_PxIxI_1 | 55 | 61 | PF00149 | 0.271 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.203 |
DOC_USP7_MATH_1 | 208 | 212 | PF00917 | 0.320 |
DOC_USP7_UBL2_3 | 241 | 245 | PF12436 | 0.287 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.271 |
DOC_WW_Pin1_4 | 99 | 104 | PF00397 | 0.309 |
LIG_14-3-3_CterR_2 | 304 | 307 | PF00244 | 0.409 |
LIG_Actin_WH2_2 | 103 | 121 | PF00022 | 0.348 |
LIG_AP2alpha_1 | 92 | 96 | PF02296 | 0.264 |
LIG_BRCT_BRCA1_1 | 168 | 172 | PF00533 | 0.357 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.261 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.400 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.321 |
LIG_FHA_2 | 193 | 199 | PF00498 | 0.247 |
LIG_GBD_Chelix_1 | 247 | 255 | PF00786 | 0.564 |
LIG_LIR_Gen_1 | 192 | 201 | PF02991 | 0.260 |
LIG_LIR_Gen_1 | 90 | 101 | PF02991 | 0.277 |
LIG_LIR_Nem_3 | 187 | 193 | PF02991 | 0.274 |
LIG_LIR_Nem_3 | 90 | 96 | PF02991 | 0.286 |
LIG_Pex14_2 | 124 | 128 | PF04695 | 0.315 |
LIG_Pex14_2 | 134 | 138 | PF04695 | 0.292 |
LIG_Pex14_2 | 48 | 52 | PF04695 | 0.369 |
LIG_Pex14_2 | 92 | 96 | PF04695 | 0.265 |
LIG_SH2_CRK | 221 | 225 | PF00017 | 0.249 |
LIG_SH2_STAP1 | 46 | 50 | PF00017 | 0.172 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.260 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.575 |
LIG_SUMO_SIM_par_1 | 205 | 212 | PF11976 | 0.336 |
LIG_SUMO_SIM_par_1 | 97 | 102 | PF11976 | 0.170 |
LIG_TRAF2_1 | 268 | 271 | PF00917 | 0.470 |
LIG_TYR_ITIM | 26 | 31 | PF00017 | 0.469 |
LIG_UBA3_1 | 107 | 115 | PF00899 | 0.203 |
LIG_WRC_WIRS_1 | 185 | 190 | PF05994 | 0.285 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.258 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.401 |
MOD_CK2_1 | 192 | 198 | PF00069 | 0.284 |
MOD_GSK3_1 | 109 | 116 | PF00069 | 0.315 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.255 |
MOD_N-GLC_1 | 178 | 183 | PF02516 | 0.471 |
MOD_N-GLC_1 | 87 | 92 | PF02516 | 0.480 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.307 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.314 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.329 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.257 |
MOD_PIKK_1 | 154 | 160 | PF00454 | 0.406 |
MOD_Plk_1 | 211 | 217 | PF00069 | 0.350 |
MOD_Plk_1 | 87 | 93 | PF00069 | 0.280 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.373 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.324 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.271 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.271 |
MOD_ProDKin_1 | 99 | 105 | PF00069 | 0.309 |
MOD_SUMO_rev_2 | 278 | 286 | PF00179 | 0.552 |
TRG_DiLeu_BaLyEn_6 | 100 | 105 | PF01217 | 0.170 |
TRG_ENDOCYTIC_2 | 190 | 193 | PF00928 | 0.314 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.268 |
TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.361 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.652 |
TRG_ER_diArg_1 | 200 | 203 | PF00400 | 0.317 |
TRG_ER_diArg_1 | 272 | 275 | PF00400 | 0.482 |
TRG_ER_diArg_1 | 32 | 34 | PF00400 | 0.545 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 69% | 90% |
A0A0N0P6B0 | Leptomonas seymouri | 26% | 100% |
A0A0N1HTP4 | Leptomonas seymouri | 54% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 39% | 100% |
A0A0S4IQ05 | Bodo saltans | 33% | 91% |
A0A0S4IR22 | Bodo saltans | 43% | 100% |
A0A1X0P9F0 | Trypanosomatidae | 35% | 100% |
A0A3Q8IFY7 | Leishmania donovani | 28% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 35% | 100% |
A0A3S5H5E4 | Leishmania donovani | 51% | 71% |
A0A3S5H7L8 | Leishmania donovani | 35% | 95% |
A0A3S7WNW6 | Leishmania donovani | 87% | 86% |
A4H418 | Leishmania braziliensis | 58% | 100% |
A4H419 | Leishmania braziliensis | 60% | 100% |
A4H420 | Leishmania braziliensis | 72% | 100% |
A4HHM7 | Leishmania braziliensis | 37% | 100% |
A4HKI5 | Leishmania braziliensis | 29% | 100% |
A4HSA1 | Leishmania infantum | 51% | 100% |
A4HSA2 | Leishmania infantum | 87% | 86% |
A4I816 | Leishmania infantum | 28% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AE89 | Leishmania major | 34% | 100% |
E9AE90 | Leishmania major | 35% | 100% |
Q4Q582 | Leishmania major | 27% | 100% |
Q9NF90 | Leishmania major | 86% | 100% |
Q9NF91 | Leishmania major | 53% | 100% |
V5C201 | Trypanosoma cruzi | 37% | 100% |